About the company

JSI is a consulting and broadband solutions provider to the telecommunications industry in the USA. The business offers a complete range of financial, engineering, regulatory, operational, and strategic services to telecommunications providers that are focused on rural communities.

Investment rationale

Active management and value creation

About the company

Prosci is a change management firm focused on helping individuals and organisations build change management capabilities. It has a network of over 30,000 change leaders worldwide through the Prosci Change Management Certification programme.

Investment rationale

Active management and value creation

During the investment period, Leeds Equity Partners plans to focus on the following key growth drivers:

About the company

Seqens is a global chemicals and active pharmaceutical ingredients manufacturer. The company is a leading supplier of pain relief ingredients in both the Paracetamol and Aspirin supply chains. Seqens is headquartered in France with production facilities and R&D centres located globally.

Investment rationale

Our relationship

Active management and value creation

About the company

Kroll Bond Rating Agency is one of the five global full-service credit rating agencies. The business was founded in 2010 with the aim of restoring trust in credit ratings by creating new standards for assessing risk and offering transparent ratings. It is differentiated through the quality and rigour of its research, its ability to rate niche asset classes with bespoke methodologies, and its competitive pricing.

Investment rationale

Our relationship

Active management and value creation

About the company

TriMech is a provider of 3D design, engineering and manufacturing solutions in the United States and Canada. The company was founded in 1998 and is headquartered in Virginia, USA, with locations in 15 states across the country and six further locations in Canada.

Investment rationale

Our relationship

Active management and value creation

About the company

Accelerant is a technology enabled insurance exchange that connects underwriters, who do not have the capital of a traditional insurance firm, with risk capital providers. Altamont Capital Partners first backed the company in 2019 and has helped grow the business in the intervening period.

Investment rationale

About the company

CoreLogic is a provider of information and outsourced services primarily to the mortgage, real estate, and insurance sectors. CoreLogic’s services can be divided into two key segments– underwriting services (representing 66% of revenues), and property intelligence & risk management (representing 34% of revenues).

Investment Rationale

Our relationship

PIP is a primary investor in seven Insight Partners (“Insight”) funds and has acquired secondary interests in several Insight funds. In addition, PIP has participated in seven co-investments alongside the manager.

Active management and value creation

About the company

CIPHR is a UK-based provider of cloud/Software-as-a-service human capital management (“HCM”) and payroll solutions to mainly mid-market businesses. The company offers a suite of proprietary software and software from its partner network (known as ‘CIPHR Connect’), serving mainly UK customers, with several of its customers using its software in multiple geographies. CIPHR’s partner network allows greater module customisation for specific customer types.

Investment Rationale

Our relationship

PIP is a primary investor in four ECI Partners (“ECI”) funds and Pantheon holds an advisory board seat on each fund.

Active management and value creation

About the company

RAYUS (formerly known as CDI) is a leading provider of high-quality diagnostic imaging and interventional radiology. The company operates through a network of imaging centres, ambulatory surgery centres and mobile imaging solutions.

Investment Rationale

Our relationship

Active management and value creation

About the company

Kersia was founded in 1985 as a subsidiary of Groupe Roullier. The company is a leading European provider of biosecurity, disinfection and hygiene solutions for the food and beverage, farm and healthcare industries. Headquartered in Dinard, France, Kersia operates 23 manufacturing sites and has approximately 1,800 employees.

Why invest

As a leading manufacturer servicing non-cyclical end markets with stable growth prospects, Kersia has an attractive business model with demand driven by heightened regulation and established positions in key markets. IK Investment Partners (“IK”) has prior experience in the healthcare sector and the biosecurity market in particular, with a strong focus on deal origination. Given the fragmented market and current consolidation trend, further buy-and-build to accelerate growth is anticipated. Company management has a track record of successfully integrating businesses.

Our relationship

Pantheon has an established relationship with IK, dating back to the early 2000s. Pantheon is a primary investor in eight IK funds and has acquired secondary interests in several IK funds. In addition, Pantheon has participated in a number of co-investments alongside the manager. Pantheon is an Advisory Board member in six IK funds.

Active management

Together with the management team, IK has continued to develop the company through the following value creation initiatives:

Page 3 of 4
1 2 3 4